Keywords: merck, kgaa, pays, rigel, 3m, japanese, right

Merck KGaA pays Rigel $3M for Japanese right to cancer drug

Article | 19 November 2007

Print This

The USA's Rigel Pharmaceuticals says that Merck Serono, a division of Germany's Merck KGaA, has exercised its option to add ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in